Literature DB >> 11011279

[Prenatal screening for trisomy 21 with maternal serum markers: information for decision-making in pregnant women].

V Seror1, N Costet, S Ayme.   

Abstract

INTRODUCTION: French health professionals are now required to provide relevant information on the test screening for Down syndrome and its possible implications when making the test available to pregnant women. A questionnaire was designed to assess prescription modalities, explanation of results, opinion on the information received when test was offered and test results were given, and likely decision after screening.
RESULTS: The response rate was 39% (1473 questionnaires analyzed). In 90.5% of the answers, women declared that an interview had preceded test prescription. 61.2% of women were satisfied with both the clarity and quantity of explanations provided and 57.6% considered that the information had helped them decide to undergo or refuse screening. 54.1% were satisfied with the explanations of test results. Amniocentesis was proposed to 125 women, 79.2% of which decided to undergo the procedure. Their opinion concerning explanations of test results was similar to that of women who refused amniocentesis or had not yet made up their minds.
CONCLUSION: Such results demonstrate the necessity to improve and adapt the information delivered by health professionals, keeping in mind that in this type of situation, decision making requires the rapid integration of complex information.

Entities:  

Mesh:

Year:  2000        PMID: 11011279

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  3 in total

1.  A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000.

Authors:  Babak Khoshnood; Catherine De Vigan; Véronique Vodovar; Janine Goujard; François Goffinet
Journal:  BJOG       Date:  2004-05       Impact factor: 6.531

2.  Socioeconomic barriers to informed decisionmaking regarding maternal serum screening for down syndrome: results of the French National Perinatal Survey of 1998.

Authors:  Babak Khoshnood; Béatrice Blondel; Catherine de Vigan; Gérard Bréart
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

3.  Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.

Authors:  Wybo Dondorp; Guido de Wert; Yvonne Bombard; Diana W Bianchi; Carsten Bergmann; Pascal Borry; Lyn S Chitty; Florence Fellmann; Francesca Forzano; Alison Hall; Lidewij Henneman; Heidi C Howard; Anneke Lucassen; Kelly Ormond; Borut Peterlin; Dragica Radojkovic; Wolf Rogowski; Maria Soller; Aad Tibben; Lisbeth Tranebjærg; Carla G van El; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.